Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2009
10/15/2009WO2009126514A1 Compounds and compositions as kinase inhibitors
10/15/2009WO2009126346A2 Methods for prevention and treatment of infections with supraphysiological doses of mannan-binding lectin (mbl) and ficolin-mbl fusion proteins
10/15/2009WO2009126308A2 Compositions and methods for vaccine and virus production
10/15/2009WO2009126293A2 Potent chimeric nrti-nnrti bifunctional inhibitors of hiv-1 reverse transcriptase
10/15/2009WO2009126014A1 Cell receptor blocker for preventing and treating avian influenza and other diseases caused by viruses
10/15/2009WO2009125841A1 Process for production of ethynylthymidine compound using 5-methyluridine as starting raw material
10/15/2009WO2009125809A1 Piperidine derivatives
10/15/2009WO2009125808A1 Aminocyclohexyl derivative
10/15/2009WO2009125667A1 Water-based adhesive skin patch containing butenafine hydrochloride
10/15/2009WO2009125394A1 Anti human immunodeficiency antibodies and uses thereof
10/15/2009WO2009125191A1 Benzene derivatives
10/15/2009WO2009124853A1 New ruthenium complexes as catalysts for metathesis reactions
10/15/2009WO2009124653A2 Thienopyrimidines
10/15/2009WO2009124386A1 Combination therapy for the treatment of bacterial infections
10/15/2009WO2009100323A3 Methods of using carboxylic amides as antimicrobial agents
10/15/2009WO2009043465A3 Use of beta-endorphin as a therapeutic agent
10/15/2009WO2009033790A3 Use of a peptide as a therapeutic agent
10/15/2009WO2009033780A3 Use of growth hormone-releasing factor and/or k237 as a therapeutic agents
10/15/2009WO2009015000A8 Pyrazole urea derivatives used as kinase inhibitors
10/15/2009US20090258936 Cxcr2 inhibitors
10/15/2009US20090258920 Injectable formulation of antibiotic and solution for intravenous administration thereof
10/15/2009US20090258906 Cxcr2 antagonists
10/15/2009US20090258890 Topoisomerase-targeting agents
10/15/2009US20090258857 Chemical compounds
10/15/2009US20090258843 Compositions Containing Antiviral Compounds and Methods of Using the Same
10/15/2009US20090258842 such as 7-(2,4-difluorophenyl)sancycline, used for the treatment of bacterial infections in mammals
10/15/2009US20090258820 Echinocandin/carbohydrate complexes
10/15/2009US20090258815 Antiviral peptide and antiviral agent
10/15/2009US20090258098 Penetrating carrier, antifungal composition using the same and method for treatment of dermatophyte infections
10/15/2009US20090258077 Composition and method for treating or preventing white spot syndrome virus
10/15/2009US20090258038 Water-soluble compositions of bioactive lipophilic compounds
10/15/2009US20090258036 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3' -utr of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4
10/15/2009US20090258035 Avian virus vaccines and uses thereof
10/15/2009US20090258033 HCV E1E2 vaccine compositions
10/15/2009US20090258026 Anti-notch1 nrr antibodies and methods using same
10/15/2009US20090258015 Modulators of Candida Hyphal Morphogenesis and Uses Thereof
10/15/2009US20090258011 Antibodies against west nile virus and therapeutic and prophylactic uses thereof
10/15/2009US20090257984 Antifungal compositions containing the endophyte fungus alternaria alternata and or its metabolites, as antagonist agents of plasmopara viticola
10/15/2009US20090257983 Medical treatment device for treating aids by utilizing modified human immunodeficiency virus virions to insert anti-viral medications into t-helper cells
10/15/2009US20090257979 Novel Inhibitors of Hepatitis C Virus Replication
10/15/2009US20090257978 Antiviral coumpounds
10/15/2009US20090257954 Development of a simple animal model for infection by viruses and other obligate intracellular parasites
10/15/2009DE202008003509U1 Pharmazeutische Zusammensetzung zur Prophylaxe und Behandlung der Arteriosklerose, sowie zur Schmerzbekämpfung und zur Entzündungshemmung A pharmaceutical composition for the prophylaxis and treatment of atherosclerosis, as well as pain relief and inflammation
10/15/2009DE102008017853A1 Thienopyrimidine Thienopyrimidines
10/15/2009CA2720946A1 Compounds and compositions as protein kinase inhibitors
10/15/2009CA2720878A1 Thienopyrimidines
10/15/2009CA2720721A1 Combination therapy for the treatment of bacterial infections
10/15/2009CA2719531A1 New ruthenium complexes as catalysts for metathesis reactions
10/15/2009CA2719364A1 Butenafine hydrochloride-containing aqueous patch
10/14/2009EP2108655A1 Immune-modulating peptide
10/14/2009EP2108404A1 Anti-bacterial extracts from mammea americana and marchantia polymorpha
10/14/2009EP2108378A2 Non-covalent bioconjugates useful for diagnosis and therapy
10/14/2009EP2108370A1 Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
10/14/2009EP2108359A1 Warming and nonirritating lubricant compositions
10/14/2009EP2108268A1 Extract of American cranberry and use thereof.
10/14/2009EP1809639B1 8a, 9-dihydro-4a-h-isothiazolo[5,4-b] quinoline-3, 4-diones and related compounds as anti-infective agents
10/14/2009EP1732569B1 Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis
10/14/2009EP1680449B1 Non-human transgenic mammal for the constant region of the class a human immunoglobulin heavy chain and applications therof
10/14/2009EP1664096B1 Antimicrobial polypeptides
10/14/2009EP1397137B1 Hydantion derivatives as inhibitors of matrix metalloproteinases
10/14/2009EP1372710B1 Mva expressing modified hiv envelope, gag, and pol genes
10/14/2009EP1360498B1 Latent human tuberculosis diagnostic antigen and method of use
10/14/2009EP1356046B1 Cytokine receptor zcytor19
10/14/2009EP1337527B1 Indolylmaleimide derivatives as protein kinase c inhibitors
10/14/2009EP1303302B1 Use of strains of the parapox ovis virus against organ fibrosis
10/14/2009EP1232257B1 Modular transport systems for molecular substances and production and use thereof
10/14/2009EP1230268B1 Heteroclitic analogs of class i epitopes
10/14/2009EP1227843B1 Method and system to remove cytokine inhibitor in patients
10/14/2009EP1161548B2 Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein
10/14/2009EP1153129B1 Method of treating restenosis by antisense targeting of c-myc
10/14/2009EP0734251B1 Method of transmitting a biologically active material to a cell
10/14/2009CN101558066A Pyrrole derivatives with antibacterial activity
10/14/2009CN101558060A Piperidine derivative used for treating chemokine receptor 5 mediated diseases
10/14/2009CN101558059A Hepatitis C virus inhibitors
10/14/2009CN101558050A Non-nucleoside reverse transcriptase inhibitors
10/14/2009CN101557816A Methods for treating and reducing the incidence of newcastle disease
10/14/2009CN101557815A Compositions and methods for treating infectious bronchitis
10/14/2009CN101557813A Liposome treatment of viral infections
10/14/2009CN101557806A Methods and compositions using immunomodulatory compounds for the treatment and management of spirochete and other obligate intracellular bacterial diseases
10/14/2009CN101555468A Viral variants with altered susceptibility to nucleoside analogs and uses thereof
10/14/2009CN101555453A Endothelial cell bioreactor as well as preparation method and application thereof
10/14/2009CN101555283A Antibodies to non-functional p2x7 receptor, diagnosis and treatment of cancers and other conditions
10/14/2009CN101555281A Preparation method of anti-influenza A H1N1 virus specific IgY and related formulation thereof
10/14/2009CN101555273A Ligand polypeptide combined with Tie2 protein specificity and drug delivery system
10/14/2009CN101555266A Preparation method of Tibifuding
10/14/2009CN101555252A Synthetic method of antibiotic cefoxitin
10/14/2009CN101555249A Method for synthesizing famciclovir
10/14/2009CN101555241A Ampelopsin pro-dug and preparing method and application thereof
10/14/2009CN101555215A Preparation technology of doxycycline hydrochloride for injection
10/14/2009CN101555206A Angustifolia lignans, preparing method and application thereof
10/14/2009CN101554480A Improved DNA vaccines for production-type animals
10/14/2009CN101554477A Aftosa vaccine immunopotentiator
10/14/2009CN101554476A Aftosa vaccine immunopotentiator
10/14/2009CN101554455A Traditional Chinese medicine preparation for treating cold
10/14/2009CN101554442A Oral blood-clearing preparation
10/14/2009CN101554424A Traditional Chinese medicine for treating skin diseases and preparation method thereof
10/14/2009CN101554421A Traditional Chinese medicine formula for curing acute appendicitis
10/14/2009CN101554420A Radix scutellariae and humifuse euphorbia herb powder and preparation technology and quality control method thereof
10/14/2009CN101554414A Traditional Chinese medicine mixture for treating livestock and poultry virosis and preparation method thereof
10/14/2009CN101554413A Veterinary drug granule for preventing and curing avian colibacillosis and preparation method thereof
1 ... 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 ... 1798